HER2-

Junpeng Zhu1, Jin Hu2, Hao Lei3

  • 1Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Discover oncology
|November 19, 2025
PubMed
概括

人类表皮生长因子受体2 (HER2) -低乳腺癌的研究正在迅速扩大. 本文献分析揭示了全球主要研究趋势,重点关注预后因素,诊断和向治疗,以改善患者的治疗结果.